Beneficial effect of glucose-insulin- potassium infusion in noncritically ill patients has to be proven – reply

Authors


Dr Mats Bonnier, The Lundberg Laboratory for Diabetes Research, Sahlgrenska University, S-413 45 Göteborg, Sweden (fax: +46 31 41 05 73; e-mail: mats.bonnier@medic.gu.se).

No abstract is available for this article.

Ancillary